Could a simple supplement protect hearts in kidney failure?
NCT ID NCT03565913
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special form of calcium and magnesium (effervescent calcium-magnesium citrate) can slow down harmful calcium buildup in the heart and blood vessels of people with end-stage kidney disease on dialysis. About 269 adults will take either this supplement or a standard calcium treatment for up to several years. The goal is to see if the new supplement reduces heart damage and improves bone health compared to the usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD STAGE 5 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DaVita Dialysis Centers
Dallas, Texas, 75224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle zap to the neck ease restless legs in dialysis patients?
- Can a diabetes drug protect failing kidneys?
- Could a common heart drug help dialysis patients?
- New study tests two methods to prevent falls in kidney dialysis patients
- Dialysis patients may get to eat fruits again: new diet focuses on hidden potassium
- Pedaling through dialysis: could High-Intensity cycling shield hearts?